Common use of Observer Rights Clause in Contracts

Observer Rights. As long as the DLB Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the DLB Investor to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; provided, however, that, in each case such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, the Company reserves the right to withhold any information and to exclude such representatives from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline Investor or their representatives are competitors of the Company.

Appears in 7 contracts

Sources: Series C Preferred Share Purchase Agreement (China Rapid Finance LTD), Investor Rights Agreement (China Rapid Finance LTD), Series C Preferred Share Purchase Agreement (China Rapid Finance LTD)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates ▇▇▇▇ and ▇▇▇▇▇▇▇ ▇▇▇▇▇ Foundation (“Foundation”) owns not less than twenty-five percent (25%) 412,000 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement C-1 Stock (or an equivalent amount of Class A Common Shares Stock issued or issuable upon conversion thereofthereof and, in any event, subject to appropriate adjustment for stock splits, stock dividends, combinations or the like), the Company and its majority-owned subsidiaries shall invite a representative of the DLB Investor Foundation to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives provide copies of all materials that it provides minutes and consents of such Board of Directors to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boardrepresentative; provided, however, that, in each case that such representatives representative shall agree to hold such information in confidence and trust and to act in a fiduciary manner with respect to all information so providedtrust; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest. (b) As long as Canaan VIII L.P. (“Canaan”) owns not less than 250,000 shares of Series C Stock (or an equivalent amount of Class A Common Stock issued or issuable upon conversion thereof and, in any event, subject to appropriate adjustment for stock splits, stock dividends, combinations or if the DLB Investorlike), the Broadline Investor Company and its majority-owned subsidiaries shall invite a representative of Canaan to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall provide copies of all minutes and consents of such Board of Directors to such representative; provided, however, that such representative shall agree to hold such information in confidence and trust; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or their representatives are competitors portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets. (c) As long as New Enterprise Associates 12, Limited Partnership, together with its affiliates, (“NEA”) owns not less than 250,000 shares of Series B Stock (or an equivalent amount of Class A Common Stock issued or issuable upon conversion thereof and, in any event, subject to appropriate adjustment for stock splits, stock dividends, combinations or the like), the Company shall provide copies of all minutes and consents of the Company’s Board of Directors to NEA; provided, however, that such representative shall agree to hold such information in confidence and trust; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets. (d) As long as A.M. ▇▇▇▇▇▇ Life Science Ventures IV, L.P. (“▇▇▇▇▇▇”) owns not less than 250,000 shares of Series C Stock (or an equivalent amount of Class A Common Stock issued or issuable upon conversion thereof and, in any event, subject to appropriate adjustment for stock splits, stock dividends, combinations or the like), the Company and its majority-owned subsidiaries shall invite a representative of ▇▇▇▇▇▇ to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall provide copies of all minutes and consents of such Board of Directors to such representative; provided, however, that such representative shall agree to hold such information in confidence and trust; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets. (e) As long as (I) Glaxo Group Limited (“GSK”) owns shares of Series C-1 Stock or Series D Stock (or shares of Class A Common Stock issued upon conversion thereof) that constitute at least 2.0% of the total number of shares of Class A Common Stock of the Company on a fully diluted and as-converted basis, and (II) GSK continues to have the right to exercise at least one of the Options (defined below) or has exercised an Option, (A) the Company and its majority-owned subsidiaries shall provide copies of financial reports and other management presentations to the Company’s Board of Directors (or to the Board of Directors of its majority-owned subsidiaries) and (B) the Company shall make available the Company’s chief executive officer and chief financial officer at mutually acceptable times/locations (including by telephonic means) with representative(s) of GSK at least once per calendar quarter upon reasonable prior notice from GSK; provided, however, that GSK shall agree to hold such information in confidence and trust; and, provided further, that the Company reserves the right to withhold any information if access to such information could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest. The “Options” mean any of the Liquidia Respiratory Option or the Inhaled Option, as such terms are defined in the Inhaled Collaboration Agreement between GSK and the Company entered into on or about June 15, 2012 or the Vaccine Option, the Conjugation-by-Proxy Option, the Right of First Refusal for Liquidia Live Replication Virus Vaccine, the Liquidia Pneumo Vaccine Option or the Liquidia Malaria Vaccine Option as such terms are defined in the Vaccines Collaboration Agreement between GSK and the Company entered into on or about June 15, 2012. The rights in this Section 2.5(e) are personal to GSK and shall in no event be assignable to any person or entity without the express consent of the Company as may be determined in its sole discretion. (f) As long Xeraya LT Ltd, a Cayman Islands company (“Xeraya”), owns any shares of Series D Stock (or any shares of Class A Common Stock issued upon conversion thereof), the Company and its majority-owned subsidiaries shall invite a representative of Xeraya to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall provide copies of all minutes and consents of such Board of Directors to such representative; provided, however, that such representative shall agree to hold such information in confidence and trust; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets.

Appears in 3 contracts

Sources: Investors’ Rights Agreement (Liquidia Technologies Inc), Investors’ Rights Agreement, Investors’ Rights Agreement (Liquidia Technologies Inc)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates owns not less than twenty-five percent (25%) Lead Investors collectively own at least 5.69% of the Series B Preferred Capital Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof)then outstanding, the Company shall invite a representative of the DLB Investor Lead Investors to attend all regular meetings of the Company’s its and any of its Key Subsidiaries’ board of advisors (the “Advisory Board”) directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that (i) such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so providedprovided in accordance with Subsection 3.7 as if such representative were a “Holder”; and provided further, that, in each case, (ii) the Company reserves the right to withhold any information and or to exclude such representatives representative from any meeting or portion thereof if (x) access to such information or attendance at such meeting could adversely affect would (i) as advised by the counsel of the Company in writing, result in the loss of the attorney-client privilege between the Company or any of its Key Subsidiaries and its counsel counsel; provided that the Company or such Key Subsidiary, as applicable, shall use commercially reasonable efforts, including by entering into a joint defense agreement, common interest agreement or other arrangement to enhance the ability of the parties to protect their communications and other reviewed materials under the attorney client privilege, to permit the disclosure of such information without significant risk of losing such privilege, or (ii) result in disclosure of trade secrets or a conflict of interest, or (y) if the DLB Investorrepresentative of the Lead Investors is a Competitor. The information provided to the Lead Investors pursuant to this Subsection 3.5(a) shall not be required to be translated from its native language unless the Lead Investors so request and agree to bear all out-of-pocket costs for such translation. (b) At the reasonable request of the Key Holders, the Broadline Investor Company shall invite a representative of the Key Holders to attend all meetings of its and any of its Key Subsidiaries’ board of directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that (i) such representative shall agree to hold in confidence and trust all information so provided in accordance with Subsection 3.7 as if such representative were a “Holder”; and (ii) that the Company reserves the right to withhold any information or to exclude such representative from any meeting or portion thereof if (x) access to such information or attendance at such meeting would (i) as advised by the counsel of the Company in writing, result in the loss of the attorney-client privilege between the Company or any of its Key Subsidiaries and its counsel; provided that the Company or such Key Subsidiary, as applicable, shall use commercially reasonable efforts, including by entering into a joint defense agreement, common interest agreement or other arrangement to enhance the ability of the parties to protect their communications and other reviewed materials under the attorney client privilege, to permit the disclosure of such information without significant risk of losing such privilege, or (ii) result in disclosure of trade secrets or a conflict of interest, or (y) if the representative of the Key Holders or their representatives are competitors of representative is a Competitor. The information provided to the CompanyKey Holders pursuant to this Subsection 3.5(b) shall not be required to be translated from its native language unless a Key Holders so requests and agrees to bear all out-of-pocket costs for such translation.

Appears in 3 contracts

Sources: Investors’ Rights Agreement, Investors’ Rights Agreement (BeiGene, Ltd.), Investors’ Rights Agreement (BeiGene, Ltd.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Sequoia Capital owns not less than twenty-five one percent (251%) of the Series B outstanding shares of Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Sequoia Capital to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest, to such representative or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is or is affiliated with a direct competitor of the Company. (b) As long as Lightspeed Venture Partners (“Lightspeed”) owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Lightspeed to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (c) As long as Harmony owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Harmony to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (d) As long as OrbiMed owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of OrbiMed to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (e) As long as Claremont Creek Ventures owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Claremont Creek Ventures to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (f) As long as HealthCor owns at least 2,382,757 shares of Series E Preferred Stock (subject to appropriate adjustment for stock splits, stock dividends, combinations or the like), the Company shall invite a representative of HealthCor to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (g) As long as Sofinnova owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Sofinnova to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company.

Appears in 2 contracts

Sources: Investors’ Rights Agreement, Investors’ Rights Agreement (Natera, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates ▇▇▇▇▇▇▇-▇▇▇▇▇ Squibb Company, Tax ID No: ▇▇-▇▇▇▇▇▇▇ (“BMS”) owns not less than twenty-five percent (25%) shares of the Series B C-2 Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor BMS to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) Board in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the DLB InvestorCompany to the extent such information or portion of such meeting involves competitive sensitive information. (b) As long as Merck Ventures BV, Reg. No. 601910929 (“Merck”) owns shares of the Series C-2 Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Broadline Company shall invite a representative of Merck to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or their representatives are competitors its representative is a Competitor of the Company to the extent such information or portion of such meeting involves competitive sensitive information. (c) So long as Soleus owns shares of Series D Preferred Stock (or Common Stock issued upon conversion thereof) and an Affiliate of Soleus is not a member of the Board, the Company shall invite a representative of Soleus to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company to the extent such information or portion of such meeting involves competitive sensitive information. (d) So long as Eir owns shares of Series D Preferred Stock (or Common Stock issued upon conversion thereof) and an Affiliate of Eir is not a member of the Board, the Company shall invite a representative of Eir to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company to the extent such information or portion of such meeting involves competitive sensitive information. (e) So long as Hadean owns shares of Series D Preferred Stock (or Common Stock issued upon conversion thereof) and an Affiliate of Hadean is not a member of the Board, the Company shall invite a representative of Hadean to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (f) Any Investor that may from time to time designate a member of the Board pursuant to the Voting Agreement, dated of even date herewith, by and among the Company and the other parties thereto (the “Voting Agreement”) may, at such Investor’s sole discretion, elect to keep such seat vacant, and may, in place of such Board designee, invite a representative of such Investor to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, the Company shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided that if such Board designee is nominated by such Investor, the observer rights set forth in this Subsection 3.3 shall be suspended for so long as the Board designee shall remain on the Board.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (Galecto Inc.), Investors’ Rights Agreement (Galecto Inc.)

Observer Rights. (a) As long as ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ or ▇▇▇▇▇▇▇ Investments, LLC shall own any shares of capital stock of the DLB Investor Company, (b) as long as Columbia Ventures Corporation (“CVC”) shall own at least 287,769 shares of Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), (c) as long as KBI shall own at least 178,754 shares of Preferred Stock (as adjusted for any of stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), and (d) as long as ▇▇▇▇▇▇▇ Innovation Center LLC and its Affiliates owns not less than twenty-five percent (25%collectively, “DIC”) shall own at least 153,218 shares of Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereofdate hereof), respectively, the Company shall invite a representative of ▇▇. ▇▇▇▇▇▇▇, a representative of CVC, a representative of KBI, and a representative of DIC, as the DLB Investor case may be, to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such ▇▇. ▇▇▇▇▇▇▇, and the CVC, KBI, and DIC representatives copies of all notices, minutes, consents and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in that each case such representatives observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor. Each of the Investors agrees that except as expressly set forth above, no other Investor or stockholder of the Company is entitled to any Board observer rights, and any and all observer rights between the Company or any of its predecessors and any other Investor or stockholder of the Company, including without limitation those set forth in the Fifth Amended and Restated Limited Liability Company Agreement of AbSci, LLC, dated December 5, 2019, as amended, restated or otherwise modified from time to time.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (AbSci Corp), Investors’ Rights Agreement (AbSci Corp)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Deep Track Capital owns not less than twenty-five forty percent (2540%) of the shares of the Series B C Preferred Shares Stock it has purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof)Agreement, the Company shall invite a representative of the DLB Investor Deep Track Capital to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at substantially the same time and in substantially the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor of the Company. (b) As long as Vida owns not less than forty percent (40%) of the shares of the Series C Preferred Stock it has purchased under the Purchase Agreement, the Company shall invite a representative of Vida to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at substantially the same time and in substantially the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company

Appears in 2 contracts

Sources: Investors' Rights Agreement (Lb Pharmaceuticals Inc), Investors' Rights Agreement (Lb Pharmaceuticals Inc)

Observer Rights. As long as the DLB Investor or any of GPP – Connecture, LLC and its Affiliates (“GPP”) owns not less than twenty-five percent (25%) 5,000,000 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof, in each case subject to appropriate adjustment for stock splits, combinations, recapitalizations or the like with respect to such shares), and does not have a representative then serving on the Board, the Company shall invite a representative of the DLB Investor GPP to attend all regular meetings of the Company’s board of advisors its Board (the and any committee thereof) in a nonvoting observer capacity. As long as SSM Venture Partners II, L.P. and its Affiliates (“Advisory BoardSSM”) in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) 2,500,000 shares of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement A Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof, in each case subject to appropriate adjustment for stock splits, combinations, recapitalizations or the like with respect to such shares), and does not have a representative then serving on the Board, the Company shall invite a representative of the Broadline Investor SSM to attend all regular meetings of the Company’s Advisory its Board (and any committee thereof) in an a nonvoting observer capacity andcapacity. As long as Live Oak Equity Partners, L.P. and its Affiliates (“Live Oak”) owns not less than 2,500,000 shares of Series A Stock (or equivalent amount of Common Stock issued upon conversion thereof, in this respecteach case subject to appropriate adjustment for stock splits, combinations, recapitalizations or the like with respect to such shares), and does not have a representative then serving on the Board, the Company shall invite a representative of Live Oak to attend all meetings of its Board (and any committee thereof) in a nonvoting observer capacity. The Company shall give such representatives copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Boarddirectors; provided, however, that, in each case such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. The Company shall reimburse the reasonable costs and expenses of each observer of GPP, or if the DLB Investor, the Broadline Investor or their representatives are competitors SSM and Live Oak incurred in attending meetings of the Board (including any meeting of committees of the Board) and any other meetings or events attended on behalf of the Company at the Company’s request.

Appears in 2 contracts

Sources: Investor Rights Agreement (Connecture Inc), Investor Rights Agreement (Connecture Inc)

Observer Rights. As For so long as at least 1,750,000 shares of Series A-2 Preferred Stock remain outstanding, the DLB Investor or any Company shall allow one representative of its Affiliates the holders of a majority of Series A-2 Preferred Stock to attend all meetings of the Board in a nonvoting observer capacity, which representative shall initially be ▇▇▇▇▇ ▇▇▇▇▇▇. In addition, the Company shall allow one representative of Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P. (collectively, “Altitude”), for so long as Altitude owns not less than twenty-five twenty percent (2520%) of the shares of the Series B A-1 Preferred Shares Stock it purchased is purchasing under the Series B Share Purchase Agreement and does not have one (or an equivalent amount of Common Shares issued upon conversion thereof)1) Affiliate then serving on the Board, the Company shall invite a representative of the DLB Investor to attend all regular meetings of the Company’s board of advisors (Board in a nonvoting observer capacity. Each observer appointed pursuant to this Agreement or pursuant to any management rights letter or other agreement issued or entered into by the Company on or about the date hereof, are referred to herein as an “Observer”, and collectively, the “Advisory BoardObservers”) in an observer capacity and, in this respect, . The Company shall give such representatives the Observers copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; provided, however, that, in each case such representatives directors. Observers shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, the . The Company reserves the right to withhold any information and to exclude such representatives an Observer from any meeting or portion thereof if reasonably determined that access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor of the Company.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (Vir Biotechnology, Inc.), Investors’ Rights Agreement (Vir Biotechnology, Inc.)

Observer Rights. (i) As long as the DLB Investor one or any of more investment vehicles managed by Sands Capital Ventures, LLC or its Affiliates owns affiliate (together, “Sands”) collectively own not less than twenty-five percent (25%) 750,000 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement Company’s capital stock (as adjusted for subsequent stock splits, combinations, stock dividends or an equivalent amount of Common Shares issued upon conversion thereof), other similar events) the Company shall invite a representative of the DLB Investor Sands to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a competitor of the Company. (ii) As long as Tenaya Capital VI, LP (“Tenaya”) owns not less than 750,000 shares of the Company’s capital stock (as adjusted for subsequent stock splits, combinations, stock dividends or other similar events) the Company shall invite a representative of Tenaya to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. (iii) As long as OrbiMed Royalty Opportunities II, LP together with its affiliates (“OrbiMed”) owns not less than 150,000 shares of the Company’s capital stock (as adjusted for subsequent stock splits, combinations, stock dividends or other similar events) the Company shall invite a representative of OrbiMed to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company.

Appears in 2 contracts

Sources: Investor Rights Agreement (Health Catalyst, Inc.), Investor Rights Agreement (Health Catalyst, Inc.)

Observer Rights. (a) As long as the DLB Investor or any RTW holds at least 2,142,858 shares of its Affiliates owns not less than twenty-five percent (25%) of the Series B A-1 Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof, excluding any Common Stock issued upon conversion of the Series A-1 Preferred Stock pursuant to the “Special Mandatory Conversion” provisions of the Certificate of Incorporation), the Company shall invite a representative of the DLB Investor RTW to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline applicable Investor or their representatives are competitors its representative is a Competitor of the Company. (b) As long as Nextech holds at least 2,142,858 shares of Series A-1 Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof, excluding any Common Stock issued upon conversion of the Series A-1 Preferred Stock pursuant to the “Special Mandatory Conversion” provisions of the Certificate of Incorporation), the Company shall invite a representative of Nextech to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the applicable Investor or its representative is a Competitor of the Company. (c) Upon and after the Third Tranche Closing (as defined in the Purchase Agreement), as long as Red Tree holds at least 728,572 shares of Series A-1 Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof, excluding any Common Stock issued upon conversion of the Series A-1 Preferred Stock pursuant to the “Special Mandatory Conversion” provisions of the Certificate of Incorporation), the Company shall invite a representative of Red Tree to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the applicable Investor or its representative is a Competitor of the Company.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (CARGO Therapeutics, Inc.), Investors’ Rights Agreement (CARGO Therapeutics, Inc.)

Observer Rights. As long as the DLB Investor or any of its Affiliates owns not less than twenty-five percent (25%i) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the The Company shall invite a representative of the DLB Investor ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, M.D., or an individual designated by ▇▇. ▇▇▇▇▇▇▇▇▇, to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) Board in an a nonvoting observer capacity and, in this respect, shall give such representatives ▇▇. ▇▇▇▇▇▇▇▇▇ or his representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, thatthat ▇▇. ▇▇▇▇▇▇▇▇▇ or, in each case such representatives if applicable, his representative, shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives ▇▇. ▇▇▇▇▇▇▇▇▇ or his representative from any meeting or portion thereof if access to such information or attendance at to such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline Investor ▇▇. ▇▇▇▇▇▇▇▇▇ or their representatives are competitors his representative is a competitor of the Company. (ii) The Company shall invite one individual designated by Hatteras (the “Hatteras Observer”), which individual shall initially be ▇▇▇▇ ▇▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give the Hatteras Observer copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that Hatteras and the Hatteras Observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude the Hatteras Observer from any meeting or portion thereof if access to such information or attendance to such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if Hatteras or the Hatteras Observer is a competitor of the Company. (iii) The Company shall invite one individual designated by Lumira Capital II, L.P. and its Affiliates (“Lumira”), which individual shall initially be ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity (the “Lumira Observer”) and, in this respect, shall give the Lumira Observer copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that Lumira and the Lumira Observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude the Lumira Observer from any meeting or portion thereof if access to such information or attendance to such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if Lumira or the Lumira Observer is a competitor of the Company. (iv) The Company shall invite one individual designated by Cormorant and its Affiliates (the “Cormorant Observer”), which individual shall initially be ▇▇▇▇▇ ▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give the Cormorant Observer copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that Cormorant and the Cormorant Observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude the Cormorant Observer from any meeting or portion thereof if access to such information or attendance to such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if Cormorant or the Cormorant Observer is a competitor of the Company.

Appears in 2 contracts

Sources: Stockholders' Agreement, Stockholders Agreement (G1 Therapeutics, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Insight owns not less than twenty-five percent (25%) 4,000,000 of the shares of Series B A-1 Preferred Shares Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification affecting such shares effected after the date hereof) it purchased under that certain Series A-1 Preferred Stock and Series A-2 Preferred Stock Purchase Agreement, dated as of December 22, 2016, by and among the Series B Share Purchase Agreement Company and certain of the Prior Investors (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Insight to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor. (b) As long as Anchorage owns not less than 2,000,000 of the DLB Investorshares of Series B-1 Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification affecting such shares effected after the date hereof) it purchased under that certain Series B Preferred Stock Purchase Agreement, dated as of August 3, 2018, by and among the Company and certain of the Prior Investors or Series B-2 Preferred Stock it purchased under that certain Series B-2 Preferred Stock Purchase Agreement, by and among the Company and the other parties listed thereto (or an equivalent amount of Common Stock issued upon conversion thereof), the Broadline Company shall invite a representative of Anchorage to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if such Investor or their representatives are competitors its representative is a Competitor. (c) As long as Tiger owns not less than 2,000,000 of the Companyshares of Series D Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification affecting such shares effected after the date hereof) it purchased under that certain Series D Preferred Stock Purchase Agreement, dated as of March 31, 2021, by and among the Company and certain of the Investors (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Tiger to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if such Investor or its representative is a Competitor. (d) As long as Spruce owns not less than 2,000,000 of the shares of Series D Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification affecting such shares effected after the date hereof) it purchased under that certain Series D Preferred Stock Purchase Agreement, dated as of March 31, 2021, by and among the Company and certain of the Investors (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Spruce to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if such Investor or its representative is a Competitor. (e) As long as BDT owns not less than 581,515 of the shares of Series E Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification affecting such shares effected after the date hereof) it purchased under that certain Series E Preferred Stock, Perpetual Preferred Stock and Common Stock Purchase Agreement, dated as of May 5, 2022, by and among the Company and certain of the Investors (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of BDT to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if such Investor or its representative is a Competitor.

Appears in 2 contracts

Sources: Investors’ Rights Agreement (EquipmentShare.com Inc), Investors’ Rights Agreement (EquipmentShare.com Inc)

Observer Rights. As long as the DLB Investor or any of its Affiliates owns "Series D Investors" collectively own not less than twenty-five percent (25%) 727,500 shares of Series D Preferred Stock of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement Company (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative designated by the holders of a majority of the DLB Investor Registrable Securities held by such Series D Investors to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, (it being understood and the Company hereby agrees that such representative shall give alternate between a representative of Hanc▇▇▇ ▇▇▇ture Partners IV - Direct Fund L.P. and a representative of Pioneer Ventures Limited Partnership as such representatives copies of all materials that it provides entities may from time to its advisors on such Advisory Board; and as time determine). As long as the Broadline Investor or any of its Affiliates MeriTech collectively owns not less than twenty-five percent (25%) 333,334 shares of Series F Preferred Stock of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement Company (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor designated by MeriTech to attend all regular meetings of the Company’s Advisory its Board of Directors in an a nonvoting observer capacity and, in this respect, capacity. The Company shall give such representatives provide to each representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in that each case such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives a representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest, or to such representative if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a direct competitor of the Company.

Appears in 2 contracts

Sources: Investors Rights Agreement (Quintus Corp), Investors Rights Agreement (Quintus Corp)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates owns Wellington Investors own, in the aggregate, not less than twenty-five percent (25%) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount 464,326 shares of Common Shares issued upon conversion thereofStock (subject to appropriate adjustment for all stock splits, stock dividends and reorganizations), the Company shall invite a representative of Wellington Management Company, LLP, on behalf of the DLB Investor Wellington Investors, to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a competitor of the Company. (b) As long as the Insight Investors own, in the aggregate, not less than 1,020,916 shares of Common Stock (subject to appropriate adjustment for all stock splits, stock dividends and reorganizations), the Company shall invite a representative of Insight Venture Partners, on .behalf of the Insight Investors, to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Ncino, Inc.)

Observer Rights. As For so long as the DLB Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ is an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the DLB Investor to attend all regular meetings employee of the Company’s board , ▇▇. ▇▇▇▇▇▇▇ shall be entitled to attend each meeting of advisors the Board in a nonvoting, observer capacity. For so long as they hold shares of Common Stock or Preferred Stock, each of Buffalo and Erie County Industrial Land Development Corporation (“BECILDC”), Rand Capital SBIC, L.P. (“Rand”), Access Technology Capital, LLC (“Access”) and Mitsui Incubase Corporation (“Mitsui”) shall be entitled to designate one (1) representative (the “Advisory BoardBECILDC Observer”, the “Rand Observer”, the “Access Observer” and the “Mitsui Observer”, respectively, and together with ▇▇. ▇▇▇▇▇▇▇, the “Observers”) to attend each meeting of the Board in an a nonvoting, observer capacity and, capacity. The Company shall send to the Observers the notice of the time and place of such meeting in this respect, the same manner and at the same time as it shall give send such representatives notice to the Board. The Company shall also provide the Observers with copies of all materials that it provides reports, minutes and consents at the time and in the manner as they are provided to its advisors on such Advisory Board; the Board and the Observers shall have access to the same information as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) members of the Series B Preferred Shares Broadline Investor purchased under Board, provided that the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company Observers shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; provided, however, that, in each case such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so providedprovided to, or obtained by, him or her pursuant to this Section 4; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives any or all of the Observers from any meeting or portion thereof if (i) access to such information or attendance at such meeting (A) could adversely affect the attorney-client privilege between the Company and its counsel or (B) would result in disclosure of trade secrets to any of the Observers or (ii) any of the Observers is a conflict of interest, or if the DLB Investor, the Broadline Investor or their representatives are competitors of direct competitor to the Company.

Appears in 1 contract

Sources: Voting Agreement (Synacor, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates owns ▇. ▇▇▇▇ Price Investors collectively own not less than twenty-five percent 400,510 shares of Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and/or Series H Preferred Stock (25%as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor ▇. ▇▇▇▇ Price to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor of the Company. (b) The Company shall invite a representative of the Durable Capital Investor to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (c) The Company shall invite one representative of the Cascade Investor to attend (in person or telephonically) all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other material that the Company provides to the members of its Board at the same time and in the same manner as provided to such members (except when the representative is excluded from a meeting in order to preserve attorney-client privilege or when the representative’s presence would result in a conflict of interest, as set forth below); provided, however, that such representative shall agree to hold in confidence and trust all information so provided in accordance with Section 3.6(a) of this Agreement; and, provided further, that the representative may be excluded from access to any material or meeting or portion thereof if the Board determines upon advice of counsel that such exclusion is reasonably necessary to preserve the attorney-client privilege between the Company and its counsel, to avoid a conflict of interest between the lawful interests of the Company and/or any of its subsidiaries, on the one hand, and the representative, on the other hand, or to protect highly confidential proprietary information.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Vroom, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates owns Group, LP and Investor Growth Capital Limited (together, “IGC”) collectively own not less than twenty-five percent (25%) 500,000 shares of the Series B A Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof) (as adjusted for stock splits, stock dividends, recapitalizations or the like), the Company shall invite a representative of the DLB Investor IGC to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest, to such representative or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is or is affiliated with a direct competitor of the Company. (b) As long as Wachovia Capital Partners 2006, LLC (“WCP”) owns not less than 500,000 shares of Series B Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) (as adjusted for stock splits, stock dividends, recapitalizations or the like), the Company shall invite a representative of WCP to attend all meetings of its Board of Directors in a non-voting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary matter with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Greenway Medical Technologies Inc)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Valor Digital Investments, LLC (“Valor”) owns not less than twenty-five percent (25%) 2,473,582 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Class A Common Shares Stock issued upon conversion thereof, in each case as adjusted proportionately for any stock split, stock combination, stock dividend or similar recapitalization event), the Company shall invite a representative of the DLB Investor Valor to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) Board in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided provided, further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline Investor ▇▇▇▇▇ or their representatives are competitors its representative is or becomes a competitor of the Company. Such representative shall initially be ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇. (b) As long as ▇▇▇▇▇▇▇ owns not less than 529,421 shares of Series B-1 Preferred Stock (or an equivalent amount of Class A Common Stock issued upon conversion thereof, in each case as adjusted proportionately for any stock split, stock combination, stock dividend or similar recapitalization event), the Company shall invite a representative of ▇▇▇▇▇▇▇ to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided, further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if ▇▇▇▇▇▇▇ or its representative is or becomes a competitor of the Company. Such representative shall initially be ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇-▇▇▇▇▇▇. (c) As long as Galaxy Digital Ventures LLC (“Galaxy Digital”) owns not less than 529,421 shares of Series B-1 Preferred Stock (or an equivalent amount of Class A Common Stock issued upon conversion thereof, in each case as adjusted proportionately for any stock split, stock combination, stock dividend or similar recapitalization event), the Company shall invite a representative of Galaxy Digital to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided, further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in a conflict of interest, or if Galaxy Digital or its representative is or becomes a competitor of the Company. Such representative shall initially be ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Bitgo Holdings, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates RA Capital owns not less than twenty-five percent (25%) 9,768,275 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor RA Capital to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives copies representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor of the Company. (b) As long as Taiho owns not less than 7,613,246 shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Taiho to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (c) As long as ▇▇▇▇▇ owns not less than 7,137,418 shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of ▇▇▇▇▇ to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (d) As long as Longwood owns not less than 6,185,763 shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Longwood to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (e) As long as UPMC owns not less than 4,758,279 shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of UPMC to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company. (f) As long as HBM Partners owns not less than 2,713,410 shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of HBM Partners to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies, at the same time, of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a Competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Werewolf Therapeutics, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates L▇▇ owns not less than twenty-five percent at least one (25%1) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof)Stock, the Company shall invite a representative of the DLB Investor L▇▇, who shall initially be R▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) Board in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided and, provided, further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline Investor such Stockholder or their representatives are competitors its representative is a competitor of the Company. (b) As long as HC2 owns at least one (1) Share of Common Stock, the Company shall invite a representative of HC2, who shall initially be A▇ ▇▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided, further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. (c) As long as PF owns at least one (1) Share of Common Stock, the Company shall invite a representative of PF, who shall initially be B▇▇▇ ▇▇▇▇▇▇▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided, further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company. (d) As long as GN owns at least one (1) Share of Common Stock, the Company shall invite a representative of GN, who shall initially be S▇▇▇▇ ▇▇▇▇▇▇, to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided, further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Stockholder or its representative is a competitor of the Company.

Appears in 1 contract

Sources: Stockholders' Agreement (Motorsport Gaming Us LLC)

Observer Rights. As For so long as the DLB Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or G▇▇▇▇▇ ▇▇▇▇▇▇▇ is an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the DLB Investor to attend all regular meetings employee of the Company’s board , M▇. ▇▇▇▇▇▇▇ shall be entitled to attend each meeting of advisors the Board in a nonvoting, observer capacity. For so long as they hold shares of Common Stock or Preferred Stock, each of Buffalo and Erie County Industrial Land Development Corporation (“BECILDC”), Rand Capital SBIC, L.P. (“Rand”), Access Technology Capital, LLC (“Access”) and Mitsui Incubase Corporation (“Mitsui”) shall be entitled to designate one (1) representative (the “Advisory BoardBECILDC Observer”, the “Rand Observer”, the “Access Observer” and the “Mitsui Observer”, respectively, and together with M▇. ▇▇▇▇▇▇▇, the “Observers”) to attend each meeting of the Board in an a nonvoting, observer capacity and, capacity. The Company shall send to the Observers the notice of the time and place of such meeting in this respect, the same manner and at the same time as it shall give send such representatives notice to the Board. The Company shall also provide the Observers with copies of all materials that it provides reports, minutes and consents at the time and in the manner as they are provided to its advisors on such Advisory Board; the Board and the Observers shall have access to the same information as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) members of the Series B Preferred Shares Broadline Investor purchased under Board, provided that the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company Observers shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; provided, however, that, in each case such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so providedprovided to, or obtained by, him or her pursuant to this Section 4; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives any or all of the Observers from any meeting or portion thereof if (i) access to such information or attendance at such meeting (A) could adversely affect the attorney-client privilege between the Company and its counsel or (B) would result in disclosure of trade secrets to any of the Observers or (ii) any of the Observers is a conflict of interest, or if the DLB Investor, the Broadline Investor or their representatives are competitors of direct competitor to the Company.

Appears in 1 contract

Sources: Voting Agreement (Synacor, Inc.)

Observer Rights. As (a) So long as the DLB Investor or any of its Affiliates ▇▇▇▇▇▇▇▇ Metal owns not less than twenty-five percent 420,229 shares of Series Seed Preferred Stock (25%) of as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereofdate hereof), the Company shall invite a representative of the DLB Investor ▇▇▇▇▇▇▇▇ Metal to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could could, upon the written advice of outside counsel to the Company, adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest. (b) So long as InVivium owns not less than 659,855 of the shares of Series C Preferred Stock (as adjusted for any stock split, stock dividend, combination, or if other recapitalization or reclassification effected after the DLB Investordate hereof) purchased pursuant to the Purchase Agreement, the Broadline Investor or their representatives are competitors Company shall invite a representative of InVivium to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could, upon the written advice of outside counsel to the Company, adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Alto Neuroscience, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Deerfield owns not less than twenty-five percent (25%) % of the Series B shares of the Preferred Shares Stock that it purchased is purchasing under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Deerfield to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if . (b) As long as ▇▇▇▇▇▇▇▇▇ owns 25% of the DLB Investorshares of the Preferred Stock that it holds as of the date hereof, the Broadline Investor or their representatives are competitors Company shall invite a representative of Petrichor to attend all meetings of the CompanyBoard of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Aurion Biotech, Inc.)

Observer Rights. (a) As long as the DLB Investor Foresite Capital Fund IV, L.P. or any of its Affiliates affiliates (“Foresite”), in the aggregate, owns not less than twenty-five percent (25%) at least 2,464,512 shares of the Series B D Preferred Shares it purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof)Stock, the Company shall invite a representative of the DLB Investor Foresite to attend all regular meetings of the Company’s board of advisors (the “Advisory Board”) Board in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a competitor of the Company. (b) As long as venBio Global Strategic Fund II, L.P. or any of its affiliates (“venBio”), in the aggregate, owns at least 2,464,512 shares of Series D Preferred Stock, the Company shall invite a representative of venBio to attend all meetings of the Board in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in

Appears in 1 contract

Sources: Investor Rights Agreement (Turning Point Therapeutics, Inc.)

Observer Rights. (a) As long as the DLB Investor or any of Westlake (together with its Affiliates Affiliates) owns not less than twenty-five percent (25%) 5,698,198 shares of the Series B A Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Westlake to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline Investor such representative or their representatives are competitors its Affiliates is a Competitor of the Company. (b) As long as 5AM Ventures (together with its Affiliates) owns not less than 5,062,925 shares of Series A Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of 5AM Ventures to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such representative or its Affiliates is a Competitor of the Company. (c) As long as Foresite owns not less than 9,902,441 shares of Series A-2 Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Foresite to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such representative or its Affiliates is a Competitor of the Company. (d) As long as Blue Owl (together with its Affiliates) owns not less than 3,178,801 shares of Series B Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Blue Owl to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such representative or its Affiliates is a Competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Latigo Biotherapeutics, Inc.)

Observer Rights. (a) As long as ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ is an employee (but not a member of the DLB Investor or any Board of its Affiliates Directors) of the Company and owns not less greater than twenty-five one percent (251%) of the Series B Preferred Shares it purchased under shares of the Series B Share Purchase Agreement Company’s Common Stock (or an equivalent amount after giving effect to conversion into Common Stock of Common Shares issued upon conversion thereofall outstanding securities), the Company shall invite a representative of the DLB Investor ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives observer copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure counsel. (b) As long as ▇▇▇▇ ▇▇▇▇▇▇ is an employee (but not a member of trade secrets or a conflict the Board of interest, or if Directors) of the DLB Investor, Company and owns greater than one percent (1%) of the Broadline Investor or their representatives are competitors shares of the Company’s Common Stock (after giving effect to conversion into Common Stock of all outstanding securities), the Company shall invite ▇▇▇▇ ▇▇▇▇▇▇ to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such observer copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel. (c) As long as ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ is an employee (but not a member of the Board of Directors) of the Company and owns greater than one percent (1%) of the shares of the Company’s Common Stock (after giving effect to conversion into Common Stock of all outstanding securities), the Company shall invite ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such observer copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel. (d) As long as GIM owns not less than 895,416 shares of the Series C Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of GIM to attend all meetings of the Board of Directors and committee meetings (including executive sessions) in a nonvoting observer capacity in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold all information so provided in confidence on the same basis as if such information had been provided directly to GIM; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if (i) access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel and the Company has withheld any such information from, or excluded from any such meeting or portion thereof, all Persons invited to attend the meetings of the Board of Directors pursuant to this Subsection 3.3 or (ii) if such Investor or its representative is, as determined by the Board of Directors reasonably and in good faith, a Competitor of the Company. Such representative shall initially be ▇▇▇▇ ▇▇▇▇▇▇▇. (e) As long as LEC owns not less than 716,333 shares of the Series C Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of LEC to attend all meetings of the Board of Directors and committee meetings (including executive sessions) in a nonvoting observer capacity in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold all information so provided in confidence on the same basis as if such information had been provided directly to LEC; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if (i) access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel and the Company has withheld any such information from, or excluded from any such meeting or portion thereof, all Persons invited to attend the meetings of the Board of Directors pursuant to this Subsection 3.3 or (ii) if such Investor or its representative is, as determined by the Board of Directors reasonably and in good faith, a Competitor of the Company. Such representative shall initially be ▇▇▇▇▇ ▇▇▇▇▇▇. (f) As long as ▇. ▇▇▇▇ Price Investors collectively own not less than 889,813 shares of Series D Preferred Stock (or the equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of ▇. ▇▇▇▇ Price to attend all meetings of the Board of Directors and committee meetings (including executive sessions) in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold all information so provided in confidence on the same basis as if such information had been provided directly to ▇. ▇▇▇▇ Price; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if (i) access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel and the Company has withheld any such information from, or excluded from any such meeting or portion thereof, all Persons invited to attend the meetings of the Board of Directors pursuant to this Subsection 3.3 or (ii) if ▇. ▇▇▇▇ Price or its representative is, as determined by the Board of Directors reasonably and in good faith, a Competitor of the Company. Such representative shall initially be ▇▇▇▇▇ ▇▇▇.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Toast, Inc.)

Observer Rights. As (a) For so long as the DLB Investor or any group of its Affiliates owns not less than twenty-five purchasers of shares of Series B Preferred Stock of the Company (the “Series B Shares”) affiliated with KPCB Holdings, Inc. (the “▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors”) pursuant to the Series B Preferred Stock Purchase Agreement dated July 13, 2007, as amended (the “Series B Purchase Agreement”), hold, in the aggregate, at least thirty percent (2530%) of the aggregate number of Series B Preferred Shares it purchased under (as adjusted for Recapitalizations, as defined in the Series B Share Purchase Agreement (or an equivalent amount of Common Shares Certificate) initially issued upon conversion thereof)to the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors, the Company shall invite a representative of the DLB Investor ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Boarddirectors; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Board; provided, provided however, that, in each case such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if the Company determines, upon consultation with counsel, as appropriate, that (i) access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel counsel; (ii) access to such information or attendance at such meeting could result in disclosure of trade secrets to the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors or their representative; or (iii) access to such information or attendance at such meeting could result in a material conflict of interestinterest between the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors or their representative and the Company. The ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors agree, and any representative of the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors will agree, to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to them or learned by them in connection with their rights hereunder, except to the extent otherwise required by law and any other regulatory process to which the ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Investors are subject. (b) For so long as the group of purchasers of shares of Series E Preferred Stock of the Company affiliated with Institutional Venture Partners XIII, L.P. (the “IVP Investors”) pursuant to the Series E Preferred Stock Purchase Agreement, hold, in the aggregate, at least thirty percent (30%) of the aggregate number of Series E Shares (as adjusted for Recapitalizations, as defined in the Certificate) initially issued to the IVP Investors, the Company shall invite a representative of the IVP Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided however, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if the DLB InvestorCompany determines, upon consultation with counsel, as appropriate, that (i) access to such information or attendance at such meeting could adversely affect the Broadline Investor attorney-client privilege between the Company and its counsel; (ii) access to such information or attendance at such meeting could result in disclosure of trade secrets to the IVP Investors or their representatives are competitors representative; or (iii) access to such information or attendance at such meeting could result in a material conflict of interest between the IVP Investors or their representative and the Company. The IVP Investors agree, and any representative of the CompanyIVP Investors will agree, to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to them or learned by them in connection with their rights hereunder, except to the extent otherwise required by law and any other regulatory process to which the IVP Investors are subject.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Aerohive Networks, Inc)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates CEVF owns not less than twenty-five fifty percent (2550%) of the Series B shares of Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof) held as of the date of the Final Closing (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite a one (1) representative of the DLB Investor from CEVF to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a competitor of the Company. (b) As long as ▇▇▇▇▇-▇▇▇▇▇ owns not less than fifty percent (50%) of the shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) held as of the date of the Final Closing (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite one (1) representative from ▇▇▇▇▇-▇▇▇▇▇ to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. (c) As long as MMCF owns not less than fifty percent (50%) of the shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) held as of the date of the Final Closing (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite one (1) representative from MMCF to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. (d) As long as ▇▇ ▇▇▇▇▇▇▇ & Company Limited (“DCT”) purchases at least 392,798 shares of Series B Preferred Stock at the Initial Closing and owns not less than fifty percent (50%) of the shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) held as of the date of the Final Closing (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite one (1) representative from DCT to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. (e) As long as Equinor Ventures AS (“Equinor”) purchases at least 392,797 shares of Series B Preferred Stock at the Initial Closing and owns not less than fifty percent (50%) of the shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) held as of the date of the Final Closing (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof), the Company shall invite one (1) representative from Equinor to attend all meetings of the Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, that such representative shall agree to hold in confidence all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company.

Appears in 1 contract

Sources: Second Amended and Restated Investors’ Rights Agreement (NTH Cycle Inc.)

Observer Rights. (a) As long as the DLB Investor or any of its Affiliates Sequoia Capital owns not less than twenty-five one percent (251%) of the Series B outstanding shares of Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Sequoia Capital to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest, to such representative or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is or is affiliated with a direct competitor of the Company. (b) As long as Lightspeed Venture Partners (“Lightspeed”) owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Lightspeed to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (c) As long as Harmony owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Harmony to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (d) As long as OrbiMed owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of OrbiMed to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. (e) As long as Claremont Creek Ventures owns not less than one percent (1%) of the outstanding shares of Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Claremont Creek Ventures to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Natera, Inc.)

Observer Rights. (a) As long as the DLB Investor SOSventures, LLC (“SOS”), individually or any of together with its Affiliates Affiliates, owns not less than twenty-twenty five percent (25%) of the Series B shares of the Preferred Shares it purchased under the Series B Share Purchase Agreement Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor SOS to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents, and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a competitor of the Company. (b) As long as Seven Peaks Ventures Fund I, LP (“Seven Peaks”), individually or together with its Affiliates, owns not less than twenty five percent (25%) of the shares of the Series Seed Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of Seven Peaks to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Kindara, Inc.)

Observer Rights. As long as the DLB Investor or any of Accel Europe, L.P. (“Accel”), together with its Affiliates affiliates, owns not less than twenty-five at least ten percent (2510%) of the Series B Preferred Shares it purchased under outstanding shares of the Series B Share Purchase Agreement A Preferred Stock (or an equivalent amount of Common Shares Stock issued upon conversion thereof) owned by Accel immediately following the Closing (as defined in the Series A Agreement) (as adjusted for stock splits, stock dividends, recapitalizations or the like) and Jerusalem Venture Partners, L.P. (“JVP”), together with its affiliates, owns at least ten percent (10%) of the outstanding shares of Series A Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) owned by JVP immediately following the Closing, and Svenska Industrifonden (“Industrifonden”) owns at least ten percent (10%) of the outstanding shares of Series AA Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof) (as adjusted for stock splits, stock dividends, recapitalizations or the like), the Company shall invite a representative of the DLB Investor each of Accel, JVP and Industrifonden to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives representative copies of all notices, minutes, consents and other materials that it provides to its advisors on such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree in writing to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and and, provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in disclosure of trade secrets or a conflict of interest, to such representative or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is or is affiliated with a direct competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Qlik Technologies Inc)

Observer Rights. As long as Atlas owns not less than fifty percent (50%) of the DLB Investor or any shares of Series Seed 3 Preferred Stock it holds as of the date hereof, the Company shall invite a representative of Atlas to attend all meetings of its Affiliates Board of Directors in a nonvoting observer capacity. As long as NEA owns not less than fifty percent (50%) of the shares of Series Seed 3 Preferred Stock it holds as of the date hereof, the Company shall invite a representative of NEA to attend all meetings of its Board of Directors in a nonvoting observer capacity. As long as MPH holds at least 50% of the shares of Series A Preferred Stock purchased by it under that certain Series A Preferred Stock Purchase Agreement, the Company shall invite a representative of MPH to attend all meetings of its Board of Directors in a nonvoting observer capacity. As long as Surveyor owns not less than twenty-five percent (25%) of the Series B Preferred Shares it purchased under shares of the Series B Share Purchase Agreement A Preferred Stock it holds as of the date hereof (or an equivalent amount of Common Shares Stock issued upon conversion thereof), the Company shall invite a representative of the DLB Investor Surveyor to attend all regular meetings of the Company’s board Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in capacity. In this respect, the Company shall give such representatives copies of all notices, minutes, consents and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided provided, further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives representative from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors its representative is a Competitor of the Company.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Frequency Therapeutics, Inc.)

Observer Rights. As long as each of (a) Asia Ventures III L.P. and F-Prime Capital Partners Healthcare Fund IV LP (collectively, “Fidelity”) together with its Affiliates, (b) BC dcyto Limited (“3E-Bio”) together with its Affiliates (which shall include Bencao 3E Bioventures Limited provided that Bencao 3E Bioventures Limited holds any shares of the DLB Investor or any of Series B Preferred Stock), (c) Orbimed together with its Affiliates, and (d) LYFE Mount Hood Limited (“LYFE”) together with its Affiliates owns not less than twenty-five percent (25%) 1,000,000 shares of the Series B Preferred Shares it purchased under the Series B Share Purchase Agreement (Stock or an equivalent amount number of shares of Common Shares Stock issued upon conversion thereofthereof (subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations), the Company shall invite a representative of the DLB Investor Fidelity, a representative of 3E-Bio, a representative of Orbimed and a representative of LYFE to attend all regular meetings of the Company’s board its Board of advisors (the “Advisory Board”) Directors in an a nonvoting observer capacity and, in this respect, shall give such representatives copies of all notices, minutes, consents, and other materials that it provides to its advisors on directors at the same time and in the same manner as provided to such Advisory Board; and as long as the Broadline Investor or any of its Affiliates owns not less than twenty-five percent (25%) of the Series B Preferred Shares Broadline Investor purchased under the Series B Share Purchase Agreement (or an equivalent amount of Common Shares issued upon conversion thereof), the Company shall invite a representative of the Broadline Investor to attend all regular meetings of the Company’s Advisory Board in an observer capacity and, in this respect, shall give such representatives copies of all materials that it provides to its advisors on such Advisory Boarddirectors; provided, however, that, in each case that such representatives shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and provided further, that, in each case, that the Company reserves the right to withhold any information and to exclude such representatives from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if the DLB Investor, the Broadline such Investor or their representatives are competitors of the Companyits representative is a Competitor.

Appears in 1 contract

Sources: Investors’ Rights Agreement (Cytek BioSciences, Inc.)